Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 19;114(38):E7875-E7881.
doi: 10.1073/pnas.1708573114. Epub 2017 Sep 5.

Effects of thymic selection on T cell recognition of foreign and tumor antigenic peptides

Affiliations

Effects of thymic selection on T cell recognition of foreign and tumor antigenic peptides

Jason T George et al. Proc Natl Acad Sci U S A. .

Abstract

The advent of cancer immunotherapy has generated renewed hope for the treatment of many malignancies by introducing a number of novel strategies that exploit various properties of the immune system. These therapies are based on the idea that cytotoxic T lymphocytes (CTLs) directly recognize and respond to tumor-associated neoantigens (TANs) in much the same way as they would to foreign peptides presented on cell surfaces. To date, however, nearly all attempts to optimize immunotherapeutic strategies have been empirical. Here, we develop a model of T cell selection based on the assumption of random interaction strengths between a self-peptide and the various T cell receptors. The model enables the analytical study of the effects of selection on the CTL recognition of TANs and completely foreign peptides and can estimate the number of CTLs that can detect donor-matched transplants. We show that negative selection thresholds chosen to reflect experimentally observed thymic survival rates result in near-optimal production of T cells that are capable of surviving selection and recognizing foreign antigen. These analytical results are confirmed by simulation.

Keywords: T cell; applied probability; immunotherapy; neoantigen.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Alternative TCR–MHC interactions formulations. (A) S-MJ. Each TCR is represented by a string of amino acids, and the binding energy with a self-peptide is the sum of pairwise binding energies between the TCR amino acids and those in corresponding positions along the peptides. (B) PIRA. TCR regions (shaded dark blue in the cartoon) that bind peptide are characterized by TCR-specific binding energies for each given amino acid type, all drawn from a standard Gaussian distribution. These binding energies are assumed to be position-independent. (C) RICE. The behavior of TCR contact regions is now position-dependent (hence represented by different colors in the cartoon). A TCR is represented by a 20 × 10 array of IID standard Gaussian random variables, indicating the binding energy contribution for each amino acid/contact position pair along the peptide.
Fig. 2.
Fig. 2.
TCR recognition probability for each model. Recognition occurs whenever the interaction energy is greater than an upper threshold, En. Recognition rates as a function of threshold for (A) S-MJ as well as (B) PIRA and RICE. General recognition behavior is similar among all three formulations. In each case, 105 thymocytes are simulated to undergo selection.
Fig. 3.
Fig. 3.
Peptide potency for each model. The 104 self-peptides were ordered by “potency” or the fraction of (the 105) thymocytes recognizing them during selection simulations. Potent self-peptides were those that were recognized most often by the TCRs. The cumulative contributions of each self-peptide to negative selection were plotted in decreasing order of self-peptide potency for the S-MJ, PIRA, and RICE models. In all cases, the selection thresholds are chosen to give 50% survival. We see that, for the S-MJ model, the most potent self-peptide is responsible for roughly 90% of the selection behavior, whereas for the PIRA (RICE) model, 200 (7,100) of 104 self-peptides generate this level of selection.
Fig. 4.
Fig. 4.
RICE recognition behavior. (A and B) Probabilities for a single selected TCR to recognize (A) random peptides and (B) point mutants of self-peptides for the analytically tractable limits and for higher values of Nn. In both cases, the effect of increasing the number of negatively selecting self-peptides to Nn= 104 has a relatively small effect on recognition rates in the range of relevant values (1113) of En. The simulation averaged over all of the surviving TCRs from the initial cohort of 105, a lower estimate of the mouse T cell diversity for a single MHC (36); 104 random and point-mutant variants were tested. (C) The total recognition probability for the surviving (5× 104) TCR cohort to recognize: a random peptide (black curve) and a single-site mutant of a native peptide (red). (D) The ratio of the two recognition probabilities in C; 104 peptides of each class were tested. Included in D is the theoretical estimate of the ratio (1(1p1)Ns)/(1(1p^0)Ns), where Ns(En) is the number of TCRs that survived selection.
Fig. 5.
Fig. 5.
The effects of increasing differences in host and donor thymic self-peptides on alloreactivity percentages in the RICE model. The simulation was performed with an original cohort of 105 TCRs, of which 50% survived selection under 104 self-peptides (En=11.52). Increasing numbers of nonnative peptides [either random (black curves) or single-difference mutants (red curves)] were introduced, and the numbers of TCRs reacting to these were recorded. The theoretical estimate is from Eq. 16, with single-TCR recognition probabilities for random and single-mutant peptide taken from Fig. 4 A and B.

Similar articles

Cited by

References

    1. Couzin-Frankel J. Breakthrough of the year 2013. Cancer immunotherapy. Science. 2013;342:1432–1433. - PubMed
    1. McGranahan N, et al. Immune checkpoint blockade. Science. 2016;351:1463–1469. - PMC - PubMed
    1. Robinson J, Soormally AR, Hayhurst JD, Marsh SGE. The IPD-IMGT/HLA database - New developments in reporting HLA variation. Hum Immunol. 2016;77:233–237. - PubMed
    1. Ding L, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481:506–510. - PMC - PubMed
    1. Gubin MM, Artyomov MN, Mardis ER, Schreiber RD. Tumor neoantigens: Building a framework for personalized cancer immunotherapy. J Clin Invest. 2015;125:3413–3421. - PMC - PubMed

Publication types

LinkOut - more resources